Inventor

KWAN BYRON HUA

US6 patents

⚠️ This page may combine multiple inventors who share the name “KWAN BYRON HUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MASSACHUSETTS INST TECHNOLOGY

3 patents

US10166273B2Jan 1, 2019

Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein

MASSACHUSETTS INST TECHNOLOGY19 citations93

US9844582B2Dec 19, 2017

Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents

MASSACHUSETTS INST TECHNOLOGY38 citations92

US10888603B2Jan 12, 2021

Methods of treating cancer cells expressing tumor-associated integrins

MASSACHUSETTS INST TECHNOLOGY4 citations68

UNIV LELAND STANFORD JUNIOR

1 patent

US11096989B2Aug 24, 2021

Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein

UNIV LELAND STANFORD JUNIOR3 citations72

PARAGON THERAPEUTICS INC

1 patent

US12522655B2Jan 13, 2026

IL-23 antibody compositions and methods of use

PARAGON THERAPEUTICS INC0 citations58

SEAGEN INC

1 patent

US12421312B2Sep 23, 2025

Anti-PD-L1 antibodies and antibody-drug conjugates

SEAGEN INC0 citations51